Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes
Phillip, M, et.al Given the proven benefits of screening to reduce diabetic ketoacidosis (DKA) likelihood at the time of stage…
Demographic, Clinical, Management, and Outcome Characteristics of 8,004 Young Children With Type 1 Diabetes
Sandy, J, Tittel, S, Rompicherla, S, Karges, B, James, S, Rioles, N, Zimmerma, A, Frohlich-Reiterer,E, Maahs, D, Lanzinger, S, Craig,…
Hybrid Closed-Loop Systems and Glycemic Outcomes in Children and Adults With Type 1 Diabetes: Real-World Evidence From a U.S.-Based Multicenter Collaborative
Noor, N, Kamboj, M, Triolo, T, Polsky, S, McDonough, R, Demeterco-Berggren, C, Jacobsen, L, Sonabend, L, Ebekozien, O, DeSalvo, D…
Diabetes Technology Use for Management of Type 1 Diabetes Is Associated With Fewer Adverse COVID-19 Outcomes: Findings From the T1D Exchange COVID-19 Surveillance Registry
Noor, N, Ebekozien, O, Levin, L, Stone, S, Sparling, D, Rapaport, R, Maahs, D People with coronavirus disease 2019 (COVID-19)…
Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Impact in Type 1 and Type 2 Diabetes.
Maahs, D, Alonso, G.T, Gallagher, M.P, Ebekozien, O We commend Gregory and colleagues for their well-designed prospective study to quantify…
Type 1 Diabetes and COVID-19: Preliminary Findings From a Multicenter Surveillance Study in the U.S
Ebekozien, O, Noor, N, Gallagher, M, Alonso, T. The Centers for Disease Control and Prevention states that individuals with diabetes…
